Treatment Efficacy of Chuang Ling Ye, a Traditional Chinese Herbal Medicine Compound, on Idiopathic Granulomatous Mastitis: A Randomized Controlled Trial.
Journal
Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
02
2020
accepted:
26
05
2020
entrez:
28
7
2020
pubmed:
28
7
2020
medline:
28
7
2020
Statut:
epublish
Résumé
To explore whether Chuang Ling Ye (CLY), a traditional Chinese herbal medicine compound, could improve the treatment of idiopathic granulomatous mastitis (IGM) via decreasing inflammatory response. Herein, 40 patients with IGM who had wounds requiring dressing change were enrolled and randomly divided into two groups: the CLY group and the control group. The size of the neoplasm and pain score of patients were followed-up for 4 weeks. Local tissues were taken during dressing change and examined by commercial enzyme-linked immunosorbent assay (ELISA) kits. The levels of inflammatory markers, including interleukin-1 After treatment, the size of the neoplasm in the CLY group was significantly smaller than that in the control group (14.28 cm ± 8.96 cm vs. 21.14 cm ± 0.12 cm, External use of CLY could reduce the neoplasm of IGM by inhibiting local inflammation. This trial is registered with ChiCTR1800017744.
Identifiants
pubmed: 32714413
doi: 10.1155/2020/6964801
pmc: PMC7341429
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6964801Informations de copyright
Copyright © 2020 Jing-xian Xue et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest regarding the publication of this manuscript.
Références
Breastfeed Med. 2017 Sep;12(7):415-421
pubmed: 28731822
Molecules. 2019 Sep 17;24(18):
pubmed: 31533325
Asian Pac J Trop Biomed. 2013 Mar;3(3):244-52
pubmed: 23620847
Pathology. 2018 Dec;50(7):742-747
pubmed: 30389215
J Ethnopharmacol. 2013 May 20;147(2):311-20
pubmed: 23518420
BMC Cancer. 2017 May 30;17(1):384
pubmed: 28558708
Drug Chem Toxicol. 2019 Jul 2;:1-7
pubmed: 31264488
Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):222-226
pubmed: 29575844
Ann Med Surg (Lond). 2018 Nov 09;36:162-167
pubmed: 30479764
J Fam Pract. 2017 Jan;66(1):38-41
pubmed: 28188314
Int J Mol Med. 2019 Jul;44(1):324-334
pubmed: 31059072
Transplant Proc. 2018 Mar;50(2):476-477
pubmed: 29579831
Breast J. 2005 May-Jun;11(3):179-82
pubmed: 15871702
Breast J. 2011 Nov-Dec;17(6):661-8
pubmed: 21951547
Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv70-6
pubmed: 16239393
Afr J Tradit Complement Altern Med. 2017 Jan 13;14(2):334-347
pubmed: 28573250
Foods. 2019 Dec 09;8(12):
pubmed: 31835429
Oncotarget. 2017 Jul 15;8(41):69768-69778
pubmed: 29050240
Pak J Pharm Sci. 2019 Jan;32(1):1-5
pubmed: 30772783
Carbohydr Polym. 2019 May 1;211:100-108
pubmed: 30824068
Acta Pharmacol Sin. 2007 Mar;28(3):404-9
pubmed: 17303004
Future Oncol. 2016 Jun;12(11):1381-94
pubmed: 27067146
J Invest Surg. 2019 Aug;32(5):414-420
pubmed: 29381437
Breast Care (Basel). 2013 Dec;8(6):439-43
pubmed: 24550752
J Gen Intern Med. 2010 Mar;25(3):270-3
pubmed: 20013067
Breast Care (Basel). 2018 Dec;13(6):413-418
pubmed: 30800035
Cytokine. 2018 Oct;110:150-158
pubmed: 29751177
Nat Rev Immunol. 2012 Feb 17;12(3):180-90
pubmed: 22343569